CD8A and neoplasm: Primitive B cells, regulatory T cells, and CD8+ T cells—tumor-killing immune cells—were less prevalent in the high-risk group than in the low-risk group, but M0 and M2 macrophages, which encourage tumor growth and progression, were more prevalent [44].